Metabolic dysfunction-associated steatotic liver disease (MASLD), also known as Non-alcoholic fatty liver disease (NAFLD), is estimated to affect up to 1 in 5 people in the UK. Rates are increasing with rising levels of obesity. Although most cases of MASLD are linked to excess weight, you can develop the disease if you have a healthy weight.

In this podcast, Dr Thomas Round talks to Dr Helen Jarvis, a GP and Clinical lecturer and researcher at Newcastle University with an interest in liver disease about fatty liver disease in primary care. 




RCGP. EKU Module on Diagnosis and management of non-alcoholic fatty liver disease. May 2024.
RCGP. Liver Toolkit. June 2025
BSG. BSG Guidelines on the management of abnormal liver blood tests. December 2021.
NICE. NG49. Non-alcoholic fatty liver disease (NAFLD): assessment and management. July 2016 (last reviewed October 2024).

Ver todos los episodios